ALHC - Public offerings

ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), an award-winning Medicare Advantage (MA) company, today announced the pricing of its previously announced underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P (the "Selling Stockholder"). The underwriter sold the shares at a public offering price of $19.46 per share. The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the Selling Stockholder. The offering is expected to close on March 4, 2026, subject to customary closing conditions. J.P.

ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), an award-winning Medicare Advantage (MA) company, today announced the commencement of an underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P. (the "Selling Stockholder"). The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the Selling Stockholder. J.P. Morgan is acting as the underwriter for the proposed offering. The offering is being made pursuant to a shelf registration statement on Form S-3, which has been filed by the Company with

ORANGE, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Continuing its forward momentum in 2023, Alignment Health — a consumer brand name of Alignment Healthcare, Inc. (NASDAQ:ALHC), a tech-enabled Medicare Advantage company — today announced the appointment of Christopher J. Joyce as its new chief legal and administrative officer (CLAO). Joyce steps into the CLAO role effective Aug. 1, reporting to Alignment Health Founder and CEO John Kao. "Chris brings a wealth of legal expertise and a proven track record of success to our organization. His deep understanding of our industry and his passion for innovation and collaboration make him a perfect fit for the position," Kao said. "Chris is joinin

ORANGE, Calif., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), a tech-enabled Medicare Advantage company, today announced the pricing of its previously announced underwritten public offering of 9,000,000 shares of its common stock by certain selling stockholders. The underwriter sold the shares at a public offering price of $14.75 per share. The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders. The offering is expected to close on September 20, 2022, subject to customary closing conditions. J.P. Morgan is acting as the underwriter

ORANGE, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), a tech-enabled Medicare Advantage company, today announced the commencement of an underwritten public offering of 9,000,000 shares of its common stock by certain selling stockholders. The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders. J.P. Morgan is acting as the underwriter for the proposed offering. A shelf registration statement on Form S-3 (including a prospectus) relating to the securities being sold in the offering was deemed automatically effective upon filing

ORANGE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ:ALHC), a tech-enabled Medicare Advantage company, today reported financial results for its fourth quarter and full year ended Dec. 31, 2021. "Our strong fourth-quarter results across critical KPIs punctuated a solid first year for Alignment Healthcare in the public markets. Our success showcased the power of our clinical model and our proprietary AVA® platform to deliver steady growth and an effective medical benefits ratio," said John Kao, founder and CEO, Alignment Healthcare. "In 2022, we will continue to invest in new markets and the replicability and scalab

ORANGE, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company"), a mission-based, tech-enabled Medicare Advantage company, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock by certain selling stockholders at $21.00 per share, including the exercise in full of the underwriters' option to purchase 1,200,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The Company will not receive any of the proceeds from the sale of the shares of its common stock by the selling stockholders, and the selling stockholde

ORANGE, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company"), a mission-based, tech-enabled Medicare Advantage company, today announced the pricing of its previously announced underwritten public offering of 8,000,000 shares of its common stock by certain selling stockholders at $21.00 per share. Such selling stockholders have granted to the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock at the public offering price, less underwriting discounts and commissions.   The Company will not receive any of the proceeds from the sale of the shares of its common stock by the selling stockholders,

ORANGE, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company"), a mission-based, tech-enabled Medicare Advantage company, today announced the launch of an underwritten public offering of 8,000,000 shares of its common stock by certain selling stockholders. Such selling stockholders also intend to grant to the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders, and the selling stockh

ORANGE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ:ALHC), a mission-based, tech-enabled Medicare Advantage company, today reported financial results for its third quarter ended September 30, 2021. "I'm pleased to be reporting another strong quarter of performance across all of our key metrics. We continued to focus our efforts on continuous improvement as we strive to deliver the highest quality care by leveraging the power of our AVA technology platform, care model and provider engagement efforts," said John Kao, founder and CEO.  "During the quarter, we further enhanced our product offerings, reflec

ORANGE, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ:ALHC), a mission-based, tech-enabled Medicare Advantage company, today reported financial results for its second quarter ended June 30, 2021. "Our results in the second quarter exceeded our expectations across the board including our membership, revenue, adjusted gross profit and adjusted EBITDA, leading us to raise our outlook for the full year of 2021," said John Kao, founder and CEO. "During the quarter, the team made notable progress on our growth strategy by entering new states, expanding to contiguous markets, and developing new, innovative customer-focused

ORANGE, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ:ALHC), a mission-based, tech-enabled Medicare Advantage company, today reported financial results for its first quarter ended March 31, 2021. "I'm incredibly proud of all Alignment Healthcare has accomplished in the first quarter of 2021, from successfully completing our initial public offering, to exceeding our expectations across each and every key performance metric, including health plan membership, revenue, adjusted gross profit, and adjusted EBITDA," said John Kao, founder and CEO. "Our founding mission -- to improve health care one senior at a time -- drives